Molecular targets for breast cancer therapy and prevention

Nature Medicine
J BangeA Ullrich

Abstract

The recent completion of the human genome sequence has raised great hopes for the discovery of new breast cancer therapies based on newly-discovered genes linked to breast cancer development and progression. Here we describe breast cancer therapies that have emerged from gene-based scientific efforts over the past 20 years and that are now approved for clinical testing or treatment.

References

Jul 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B A GustersonR Reed
May 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K LeitzelA Lipton
Jan 1, 1994·Breast Cancer Research and Treatment·R I NicholsonR W Blamey
Oct 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T SaphnerR Gray
Sep 2, 1997·Proceedings of the National Academy of Sciences of the United States of America·J S LanniT Jacks
Feb 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S SjögrenJ Bergh
Mar 12, 1998·International Journal of Cancer. Journal International Du Cancer·S RozanX Sastre-Garau
Oct 21, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R FossatiA Liberati
Feb 2, 1999·Oncogene·R VadlamudiR Kumar
Nov 5, 1999·Journal of the National Cancer Institute·M H GailV Vogel
Feb 26, 2000·Carcinogenesis·R S Kerbel
Mar 4, 2000·Journal of the National Cancer Institute·A M Senderowicz, E A Sausville
Mar 4, 2000·Nature Genetics·S A GaytherC Caldas
Mar 8, 2000·Journal of Mammary Gland Biology and Neoplasia·L M YangP Brown
Mar 29, 2000·CA: a Cancer Journal for Clinicians·R T GreenleeP A Wingo
Apr 25, 2000·Annual Review of Medicine·G Hortobagyi
Jul 27, 2000·Annals of the New York Academy of Sciences·E A SausvilleA M Senderowicz
Aug 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·V M RichonP A Marks
Aug 30, 2000·Nature·C M PerouD Botstein
Sep 6, 2000·Nature Medicine·C J TorranceC M Discafani
Sep 8, 2000·BMJ : British Medical Journal·K McPhersonJ M Dixon
Dec 7, 2000·Journal of the National Cancer Institute·R SchiffC K Osborne
Dec 13, 2000·American Journal of Surgery·S M Rosenbaum Smith, M P Osborne
Dec 21, 2000·Current Oncology Reports·R Torrisi, A Decensi
Apr 30, 2002·Gan to kagaku ryoho. Cancer & chemotherapy·Yutaka TokudaTomoo Tajima

❮ Previous
Next ❯

Citations

Jul 3, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Yi WangDonald J Hnatowich
Jul 16, 2009·Journal of Molecular Modeling·Caitlin E Cassidy, William N Setzer
Dec 26, 2002·Breast Cancer Research and Treatment·Antonino B D'AssoroJeffrey L Salisbury
May 21, 2003·Breast Cancer Research and Treatment·Tero A H Järvinen, Edison T Liu
Mar 20, 2002·Nature Reviews. Cancer·M J Bissell, D Radisky
Aug 25, 2011·Nature Reviews. Clinical Oncology·Nicholas B La Thangue, David J Kerr
Jun 8, 2011·Nature Reviews. Neurology·Sylwia Ammoun, C Oliver Hanemann
Oct 28, 2003·DNA and Cell Biology·O Guntinas-Lichius, C Wittekindt
Dec 26, 2001·Journal of the National Cancer Institute·Y LuM Pollak
Oct 27, 2009·Journal of the National Cancer Institute·Sheila E TaubeSteven I Gutman
Oct 24, 2001·Current Opinion in Oncology·P A MarksR A Rifkind
May 2, 2002·Cancer Nursing·Jennifer T LoudJean Jenkins
May 20, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Amin IsmailTony E Godfrey
Mar 2, 2006·Biological & Pharmaceutical Bulletin·Krishnamurthy VeenaPanchanatham Sachdanandam
Jan 5, 2011·Frontiers in Bioscience (Landmark Edition)·Anupam BishayeeMarjorie Perloff
Feb 8, 2013·Biomarkers in Medicine·Michael S MageeScott A Waldman
Nov 1, 2010·Therapeutic Delivery·John WatkinsDonald R J Singer
Jun 20, 2002·Proceedings of the National Academy of Sciences of the United States of America·Cemil OzcelikAlistair N Garratt
May 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·Kartiki V DesaiJeffrey E Green
Jan 23, 2003·Proceedings of the National Academy of Sciences of the United States of America·Kristi A EglandIra Pastan
Mar 14, 2002·Proceedings of the National Academy of Sciences of the United States of America·Thorsten BergPeter K Vogt
Jan 1, 2015·PeerJ·Jordan AnayaAnindya Dutta
Jan 23, 2016·Molecular Pharmaceutics·Lina Herrera EstradaJulie A Champion
Apr 22, 2006·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Joachim Fensterle
Mar 31, 2016·Journal of Enzyme Inhibition and Medicinal Chemistry·Halise Inci GulClaudiu T Supuran
Apr 29, 2015·Oncogene·C HelmkeK Strebhardt
Jan 31, 2002·Annual Review of Medicine·Rowan T Chlebowski
Oct 7, 2006·Molecular Cancer·Bernhard HemmerleinLuis A Pardo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.